Skip to content

Member

Kateřina KONEČNÁ

No group · Czechia

Group
No group NI
Country
Czechia
Roll-call participation
97.6 %ⓘ of 2 521 roll calls in office · chamber median 90.9 % · 2026, roll calls
With majority line
—ⓘ The non-attached have no group line.
More facts (5)
National party
KSČM Komunistická strana Čech a Moravy
In office
Since 16 Jul 2024
Against clear line
—ⓘ The non-attached have no group line.
Committees
ENVI (substitute), IMCO, INTA (substitute), SANT (substitute)
Member id
23699
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

97.6 %

2 460 of 2 521 roll calls while in office

Non-attached median: 87.3 %

Chamber median: 90.9 %

With majority lineⓘ

—

The non-attached have no group line.

Against clear lineⓘ

—

The non-attached have no group line.

Abstention ⓘ

11.3 %

279 of 2 460 votes cast

Participation 97.6 % — Non-attached median 87.3 %, 30 members.ⓘ
Data as a table
Participation among the 30 members of the Non-attached with enough votes.
FigureParticipation
Kateřina KONEČNÁ97.6 %
Non-attached median87.3 %
Lowest in the group38.4 %
Highest in the group99.6 %
Members30
  • 2026, 2 521 roll-call votes. The dots are the other non-attached members; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.
  • The non-attached have no group line: loyalty and votes against a clear line are not computed.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Adopted 459 for, 12 against, 86 abstainedPosition: Against Majority line: —
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Adopted 374 for, 198 against, 19 abstainedPosition: Against Majority line: —
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Adopted 514 for, 61 against, 33 abstainedPosition: For Majority line: —
17 Sept 2026Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya Adopted 562 for, 1 against, 33 abstainedPosition: Abstained Majority line: —
17 Sept 2026Impact of social media and the online environment on young people Adopted 395 for, 136 against, 80 abstainedPosition: Abstained Majority line: —
17 Sept 2026The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security Adopted 467 for, 92 against, 44 abstainedPosition: Against Majority line: —
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Adopted 368 for, 172 against, 69 abstainedPosition: For Majority line: —
17 Sept 2026Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers Adopted 601 for, 4 against, 5 abstainedPosition: For Majority line: —
17 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders Adopted 339 for, 225 against, 16 abstainedPosition: No vote recorded Majority line: —
17 Sept 2026Strengthening global health resilience in partner countries Adopted 319 for, 142 against, 19 abstainedPosition: No vote recorded Majority line: —
16 Sept 2026Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V) Passed 549 for, 92 against, 27 abstainedPosition: Against Majority line: —
16 Sept 2026Acceleration of permit-granting for defence readiness projects (Omnibus V) Passed 540 for, 105 against, 22 abstainedPosition: Against Majority line: —
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Passed 530 for, 125 against, 12 abstainedPosition: Against Majority line: —
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Passed 496 for, 53 against, 125 abstainedPosition: Against Majority line: —
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Passed 600 for, 21 against, 48 abstainedPosition: Abstained Majority line: —
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Passed 625 for, 20 against, 22 abstainedPosition: For Majority line: —
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Consent given 549 for, 75 against, 30 abstainedPosition: Abstained Majority line: —
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Consent given 640 for, 5 against, 26 abstainedPosition: For Majority line: —
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 631 for, 7 against, 15 abstainedPosition: Against Majority line: —
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 612 for, 8 against, 16 abstainedPosition: Against Majority line: —
16 Sept 2026Genetically modified soybean GMB151 x DAS-44406-6 Objection passed 442 for, 184 against, 12 abstainedPosition: For Majority line: —
16 Sept 2026Genetically modified soybean MON 94313 Objection passed 457 for, 184 against, 10 abstainedPosition: For Majority line: —
16 Sept 2026Genetically modified maize MON 87460 Objection passed 433 for, 159 against, 10 abstainedPosition: For Majority line: —
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Adopted 470 for, 129 against, 62 abstainedPosition: Against Majority line: —
16 Sept 2026An EU cardiovascular diseases strategy Adopted 545 for, 47 against, 75 abstainedPosition: For Majority line: —
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Adopted 390 for, 218 against, 29 abstainedPosition: Against Majority line: —
15 Sept 2026Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures Passed 464 for, 50 against, 159 abstainedPosition: Abstained Majority line: —
15 Sept 2026Establishing the Temporary Decarbonisation Fund Passed 433 for, 97 against, 146 abstainedPosition: Against Majority line: —
15 Sept 2026Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances Passed 367 for, 240 against, 59 abstainedPosition: Against Majority line: —
15 Sept 2026Market stability reserve for the buildings, road transport and additional sectors Passed 467 for, 158 against, 41 abstainedPosition: For Majority line: —
15 Sept 2026Implementation into Union law of measures adopted by regional fisheries management organisations Passed 559 for, 48 against, 62 abstainedPosition: For Majority line: —
15 Sept 2026General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area Passed 580 for, 51 against, 39 abstainedPosition: For Majority line: —
15 Sept 2026Temporary trade-liberalisation measures applicable to Armenian products Passed 583 for, 49 against, 39 abstainedPosition: Abstained Majority line: —
15 Sept 2026Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure Passed 440 for, 127 against, 104 abstainedPosition: Against Majority line: —
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield Adopted 420 for, 220 against, 26 abstainedPosition: Against Majority line: —
15 Sept 2026Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee Adopted 530 for, 77 against, 61 abstainedPosition: Abstained Majority line: —
15 Sept 2026The EU Youth Strategy 2019–2027 Adopted 477 for, 124 against, 66 abstainedPosition: Abstained Majority line: —
15 Sept 2026Global role of the euro Adopted 405 for, 146 against, 60 abstainedPosition: Against Majority line: —
9 Jul 2026Establishment of the digital euro Negotiating mandate approved 416 for, 169 against, 22 abstainedPosition: Against Majority line: —
9 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Adopted 476 for, 28 against, 96 abstainedPosition: No vote recorded Majority line: —
9 Jul 2026Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre Adopted 510 for, 1 against, 86 abstainedPosition: For Majority line: —
9 Jul 2026Feasibility of a 28th tax regime and its potential to support EU competitiveness Adopted 366 for, 192 against, 39 abstainedPosition: Against Majority line: —
8 Jul 2026EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement Consent given 479 for, 119 against, 65 abstainedPosition: Against Majority line: —
8 Jul 2026Protection of the environment through criminal law Consent given 499 for, 99 against, 69 abstainedPosition: For Majority line: —
8 Jul 2026EU–Mexico Interim Agreement on Trade Consent given 474 for, 131 against, 60 abstainedPosition: Against Majority line: —
8 Jul 2026EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol) Consent given 625 for, 16 against, 20 abstainedPosition: For Majority line: —
8 Jul 2026EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement Consent given 573 for, 35 against, 37 abstainedPosition: For Majority line: —
8 Jul 2026Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets Objection passed 388 for, 248 against, 24 abstainedPosition: For Majority line: —
8 Jul 2026Lead in certain fishing tackle Objection failed 197 for, 455 against, 7 abstainedPosition: For Majority line: —
8 Jul 2026Genetically modified maize NK603 × T25 Objection passed 460 for, 189 against, 14 abstainedPosition: For Majority line: —

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 2 of 34 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265858
9 Feb 202620
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141141
24 Feb 20264343
9 Mar 202610
10 Mar 2026197195
11 Mar 20266060
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202622
28 Apr 2026225224
29 Apr 2026296291
30 Apr 20266866
18 May 202644
19 May 202633
20 May 20269694
21 May 20269892
15 Jun 202622
16 Jun 20264040
17 Jun 2026127127
18 Jun 20267769
6 Jul 202622
7 Jul 20267272
8 Jul 2026144136
9 Jul 20266764
14 Sept 202611
15 Sept 2026155151
16 Sept 20268077
17 Sept 2026124110

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within No group

No member meets the rule within the group.

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Ondřej DOSTÁL No groupCzechia91 % of 5 048 shared44 %
Erik KALIŇÁK No groupSlovakia71 % of 4 885 shared44 %
Ľuboš BLAHA No groupSlovakia71 % of 4 693 shared44 %
Katarína ROTH NEVEĎALOVÁ No groupSlovakia69 % of 5 160 shared44 %
Judita LAŠŠÁKOVÁ No groupSlovakia69 % of 4 995 shared44 %
Monika BEŇOVÁ No groupSlovakia67 % of 4 252 shared44 %
Ivan DAVID ESNCzechia63 % of 4 966 shared49 %
Milan MAZUREK changed group ESNSlovakia63 % of 5 109 shared48 %
Milan UHRÍK ESNSlovakia62 % of 5 047 shared49 %
Branislav ONDRUŠ No groupSlovakia62 % of 4 079 shared44 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on the Internal Market and Consumer ProtectionIMCO CommitteeMember19 Jul 2024now
Committee on International TradeINTA CommitteeSubstitute20 May 2026now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationMember19 Sept 2024now
Delegation to the OACPS-EU Joint Parliamentary AssemblyDACP Parliamentary assemblyMember2 Apr 2025now
Delegation to the Africa-EU Parliamentary AssemblyDAFR Parliamentary assemblyMember19 Sept 2024now
Intergroup on Biodiversity, Hunting and CountrysideIG10-04 Intergroup / working groupMember4 Feb 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on DisabilityIG10-10 Intergroup / working groupMember11 Mar 2025now

Show all 16 seats

Dossiers

No rapporteur, shadow or negotiator role recorded this term.

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

70 contributions recorded; 80 minutes of speaking time.

Show all 40 recent contributions

Questions and motions, 47

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
16 Jul 2026Urgent appeal for the release of Dr Hussam Abu Safiya E-10-2026-003029Written questionwith 17 co-authors2 Sept 2026
24 Jun 2026ECB’s decision to raise interest rates and its impact on the rising cost of living O-10-2026-000028Oral questionwith 39 co-authorsNot yet answered
17 Jun 2026Circumvention of the EU-Israel Association Agreement and illegal imports from settlements in the occupied territories E-10-2026-002521Written questionwith 13 co-authors18 Sept 2026
15 Jun 2026Nuclear power and data centres E-10-2026-002448Written questionwith 13 co-authors4 Aug 2026
7 May 2026Interpretation of Annex V (Row 1) to the Packaging and Packaging Waste Regulation on grouped packaging and impact on supply chains E-10-2026-001896Written questionwith 17 co-authors16 Jul 2026
30 Apr 2026Concerns about the EU’s new age verification app E-10-2026-001771Written questionwith 10 co-authors6 Jul 2026
28 Apr 2026War in the Strait of Hormuz: measures to shield European agriculture from rising fertiliser prices O-10-2026-000022Oral questionwith 36 co-authorsNot yet answered
21 Apr 2026Customs practices related to products imported from illegal Israeli settlements in the OPTs E-10-2026-001633Written questionwith 71 co-authors16 Jul 2026
4 Mar 2026Privacy risks and GDPR compliance issues linked to Meta’s smart glasses and AI training practices P-10-2026-000903Priority written questionwith 34 co-authors1 Apr 2026
3 Mar 2026Three years since the railway accident in Tempi, Greece O-10-2026-000010Oral questionwith 35 co-authorsNot yet answered

Show all 47 questions and motions

Amendments tabled in committee, 71

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT7
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT4
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT25
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT7
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT7
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791124 ENVI8
16 Jul 2026Digital networks, amending Regulation (EU) 2015/2120, Directive 2002/58/EC and Decision No 676/2002/EC and repealing Regulation (EU) 2018/1971, Directive (EU) 2018/1972 and Decision No 243/2012/EU (Digital Networks Act) IMCO-AM-791040 IMCO2
16 Jul 2026Digital networks, amending Regulation (EU) 2015/2120, Directive 2002/58/EC and Decision No 676/2002/EC and repealing Regulation (EU) 2018/1971, Directive (EU) 2018/1972 and Decision No 243/2012/EU (Digital Networks Act) IMCO-AM-791044 IMCO2
16 Jul 2026Digital networks, amending Regulation (EU) 2015/2120, Directive 2002/58/EC and Decision No 676/2002/EC and repealing Regulation (EU) 2018/1971, Directive (EU) 2018/1972 and Decision No 243/2012/EU (Digital Networks Act) IMCO-AM-791041 IMCO15
16 Jul 2026Digital networks, amending Regulation (EU) 2015/2120, Directive 2002/58/EC and Decision No 676/2002/EC and repealing Regulation (EU) 2018/1971, Directive (EU) 2018/1972 and Decision No 243/2012/EU (Digital Networks Act) IMCO-AM-791042 IMCO5

Show all 71 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Czechia National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Kateřina KONEČNÁ”. Member record. memberId 23699. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/23699?period=2026&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/23699. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/23699?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-23699,
  author = {{EU Parl Watch Research}},
  title = {{Kateřina KONEČNÁ}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/23699?period=2026&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/23699?period=2026&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 23699. Official source: https://www.europarl.europa.eu/meps/en/23699. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}